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Abstract
Disruption of the blood-brain barrier (BBB) results in cerebral edema formation, which is a major cause for high mortality
after traumatic brain injury (TBI). As anesthetic care is mandatory in patients suffering from severe TBI it may be important
to elucidate the effect of different anesthetics on cerebral edema formation. Tight junction proteins (TJ) such as zonula
occludens-1 (ZO-1) and claudin-5 (cl5) play a central role for BBB stability. First, the influence of the volatile anesthetics
sevoflurane and isoflurane on in-vitro BBB integrity was investigated by quantification of the electrical resistance (TEER) in
murine brain endothelial monolayers and neurovascular co-cultures of the BBB. Secondly brain edema and TJ expression of
ZO-1 and cl5 were measured in-vivo after exposure towards volatile anesthetics in native mice and after controlled cortical
impact (CCI). In in-vitro endothelial monocultures, both anesthetics significantly reduced TEER within 24 hours after
exposure. In BBB co-cultures mimicking the neurovascular unit (NVU) volatile anesthetics had no impact on TEER. In healthy
mice, anesthesia did not influence brain water content and TJ expression, while 24 hours after CCI brain water content
increased significantly stronger with isoflurane compared to sevoflurane. In line with the brain edema data, ZO-1 expression
was significantly higher in sevoflurane compared to isoflurane exposed CCI animals. Immunohistochemical analyses
revealed disruption of ZO-1 at the cerebrovascular level, while cl5 was less affected in the pericontusional area. The study
demonstrates that anesthetics influence brain edema formation after experimental TBI. This effect may be attributed to
modulation of BBB permeability by differential TJ protein expression. Therefore, selection of anesthetics may influence the
barrier function and introduce a strong bias in experimental research on pathophysiology of BBB dysfunction. Future
research is required to investigate adverse or beneficial effects of volatile anesthetics on patients at risk for cerebral edema.
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Introduction
The blood-brain barrier (BBB) is a highly organized endothelial
barrier, which separates the central nervous system (CNS) from
peripheral circulation [1]. Disruption of the BBB and consecutive
vasogenic brain edema formation is one of the most deleterious
sequelae of traumatic brain injury (TBI) [2]. As a result,
intracranial pressure (ICP) may increase and contribute to the
development of secondary brain damage [3]. Pronounced edema
formation might finally lead to therapy resistant ICP increase
causing suspension of cerebral perfusion and finally leading to
brain death. Tight junction proteins (TJ) are a hallmark for the
integrity of the BBB that essentially contribute to its structural
inviolacy. Thereby paracellular flux of hydrophilic molecules
across the BBB is limited, which is essential for the functional
integrity of the CNS [4]. The TJ form a complex of transmem-
brane (junctional adhesion molecule-1, occludin, and claudins)
and cytoplasmic (zonula occludens-1 [ZO-1], zonula occludens-2
[ZO-2], cingulin, AF-6, and 7H6) proteins, which are linked to the
actin cytoskeleton [5]. The development of vasogenic brain edema
after TBI is caused by opening of the BBB and consists of protein-
rich fluid [5]. The alteration of TJ assembly may contribute to the
loss of BBB integrity and BBB breakdown [6]. It has been
suggested that different anesthetics are capable of modulating BBB
permeability [7–9]. As anesthetic care in patients suffering from
severe traumatic brain injury is mandatory it may be important to
elucidate the effect of different anesthetics on cerebral edema
formation after TBI.
In the present study, the effect of the volatile anesthetics
isoflurane and sevoflurane on barrier integrity was investigated in
an in-vitro BBB model, in-vivo in native animals and following
experimental TBI to determine the impact of anesthetic exposure
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on BBB integrity, development of vasogenic brain edema and TJ
protein integrity and expression after TBI.
Methods
Cell Culture
The murine brain endothelial cell (BEC) line bEnd.3 (American
Type Culture Collection, Manassas, VA, USA) was used as a BBB
model and cultured as recommended by the manufacturer. Cell
cultures were maintained at a humidified atmosphere, 37uC and
5% CO2. Media consisted of DMEM Glutamax supplemented
with 2% Penicillin/Streptomycin (Invitrogen GmbH, Karlsruhe,
Germany) and 15% fetal calf serum (Biochrom AG, Berlin,
Germany). bEnd.3 passages 10–19 were used for experimental
manipulations.
Neurovascular co-culture model consisting of cortical
organotypic slice cultures (COSC) and brain endothelial
cells
Co-culture procedures were carried out as described in detail
before with slight modifications regarding COSC media [10,11].
All experiments were carried out according to the national and
European (86/609/EEC) laws for use of animals in research and
approved by the institutional committee for animal care. Great
care was taken to minimize the amount of animals and their
suffering. In brief, COSC from C57/Bl6 postnatal day 3 or 4 mice
were prepared according to the Stoppini method [12]. COSC
medium was composed of 50% MEM HEPES Glutamax
containing 1 mg/ml glucose (Invitrogen GmbH, Karlsruhe,
Germany), 25% heat inactivated horse serum, 25% HBSS
supplemented with calciumchloride 2 mmol/l and magne-
siumchloride 1 mmol/l. Glucose was added to reach a concen-
tration of about 7 mg/ml. No antibiotics were used. The pH of the
medium was carefully adjusted to 7.2 at 37uC. COSC were kept in
culture for 3 days before being used for the co-culture. Slices were
carefully removed from their membranes as described in detail
before [10]. bEnd.3 media was used for co-culture procedures in
ECIS arrays. COSC were thoroughly examined for integrity with
light microscopy before using them for co-culture procedures.
Anesthetic in-vitro delivery system
The 8-well plates containing BEC or bEnd.3 and COSC co-
cultures were placed in an exposure chamber on a heating pad and
heated to 37uC. The concentrations of volatile anesthetics adjusted
with a calibrated isoflurane or sevoflurane vaporizer (Draeger,
Germany) and were confirmed by sampling the solution of the
wells and assessing the anesthetic concentration in the solution by
headspace technique using a gas chromatograph (Hewlett Packard
5890 Series II, USA).
Electrical Cell Substrate Impedance Sensing
BEC were seeded at a density of 50,000–80,000 cells per well in
an 8-well gold electrode assay (0.8 cm2 growth area, from ibidi in
cooperation with Applied BioPhysics, Martinsried, Germany). For
co-culture procedures COSC were combined with bEnd.3
similarly as described before [10]. When trans endothelial
electrical resistance (TEER) measurements reached maximal
values cells were exposed to 1.5% of isoflurane, 3.5% of
sevoflurane or room air (airR) for 20 min as described in the
previous paragraph. A calibrated vaporizer was used for this
purpose (Draeger, Germany). Thereafter bEnd.3 and co-cultures
were maintained at 37uC and 5% CO2 for 24 hours in a
humidified atmosphere. On average bEnd.3 monolayers reached
TEER values of 841.716129.94 Ohm (0.8 cm2 growth area).
TEER in co-cultures consisting of COSC and bEnd.3 monolayers
was higher than in monocultures. Here, TEER was
1171.83681.21 Ohm (0.8 cm2 growth area) on average. Only
probes that reached at least 700 Ohm were used for experiments.
24 hours after gas exposure TEER values were evaluated again
and set in relation to respective TEER values before gas exposure.
Experimental Animals
Male C57Bl6N mice (weight: 18 to 24 g, Charles River
Laboratory, Sulzfeld, Germany) were investigated. Before and
during experiments animals were cared for in compliance with
institutional guidelines of the Johannes Gutenberg-University,
Mainz. The Animal Ethics Committee of the Landesuntersu-
chungsamt Rheinland-Pfalz approved all experiments (protocol
number: 23 177-07/G08-1-012).
Anesthetic in-vivo regimens
Animals were randomized to three different anesthesia
regimens: isoflurane, sevoflurane and no anesthesia. Anesthesia
was induced in a bell jar filled with 4% isoflurane or 6%
sevoflurane and maintained via facemask in spontaneously
breathing animals (1.5% isoflurane or 3.5% sevoflurane in 40%
O2 and 60% N2). In animals randomized to no anesthesia group
an air mixture (40% O2 and 60% N2) was supplied via facemask.
Native animals (no surgery) received a 20 minutes anesthesia
exposure. In animals, which were subjected to brain trauma,
anesthesia was maintained during the surgical preparation for
about 15–20 minutes. Immediately after controlled cortical impact
(CCI) or sham surgery and closure of the wound anesthesia was
discontinued.
Trauma induction
Animals were placed in a stereotactic frame and were subjected
to brain trauma by CCI as previously described [13]. Briefly, after
craniotomy a pneumatic contusion was induced over the right
parietal cortex with a custom pneumatic controlled cortical
impactor (L. Kopacz, Mainz, Germany) with following parame-
ters: diameter 3 mm, impact velocity 8 m/s, impact duration
150 ms and the brain penetration 1 mm. Immediately after
impact the craniotomy was closed and wounds were closed with
filament sutures. Rectal temperature was maintained at 37uC by a
feedback-controlled heating pad. After discontinuation of anes-
thesia mice were returned in their individual cages and allowed to
recover for 4 hours in an incubator heated to 33uC and at a
humidity of 35% (IC8000, Draeger, Germany). Sham-operated
mice were subjected to all aspects of the protocol with exception of
the trauma.
Experimental studies
A. In-vitro: Effect of isoflurane and sevoflurane on TEER: n= 8
TEER analyses for bEnd.3 monoculture procedures, n = 8
TEER analyses for neurovascular co-cultures.
B. In-vivo: Effect of isoflurane and sevoflurane on brain water
content and TJ protein expression in healthy animals.
B. Animals (native, no surgery) were randomly assigned to three
groups: (1) 1.5% isoflurane, (2) 3.5% sevoflurane, and (3) no
anesthesia native animals (n = 8 per group). The anesthesia
was given for 20 minutes. 24 hours after anesthesia brain
water content and differential gene regulation was measured.
C. In-vivo: Effect of different anesthesia protocols on brain water
content after CCI.
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C. Hemispheric brain water content was measured 24 hours
after CCI in animals randomized to: (1) isoflurane+sham
surgery, (2) isoflurane+CCI, (3) sevoflurane+sham surgery or
(4) sevoflurane+CCI (n= 7 per group). The anesthesia was
initiated prior surgical preparation and terminated immedi-
ately after CCI and closure of the wounds.
D. In-vivo: Effect of different anesthesia protocols on immuno-
histochemical claudin 5 (cl5) and ZO-1 protein integrity in
cerebral microvessels.
D. Brain trauma was induced and animals were randomly
assigned to four groups: (1) isoflurane+sham surgery (n = 3),
(2) sevoflurane+sham surgery (n= 3), (3) isoflurane+CCI
(n= 3), (4) sevoflurane+CCI (n= 3).
E. In-vivo: Effect of different anesthesia protocols on differential
TJ gene expression after CCI.
E. Brain trauma was induced and animals were randomly
assigned to four groups: (1) isoflurane+15 min survival (n = 6),
(2) sevoflurane+15 min survival (n = 6), (3) isoflurane+24 h
survival (n = 8), (4) sevoflurane+24 h survival (n = 8), expres-
sion data were normalized with data from native, non-
operated, and anesthetized animals (n = 6, 3 animals per
anesthetic regimen).
Brain water content
24 hours after surgery or anesthesia exposure animals were re-
anesthetized with the same anesthetic regimen used during
experiments and killed by decapitation. Brains were carefully
removed and cut alongside the sagittal plane. Injured or
unharmed right hemispheres were weighed to assess their wet
weight [14]. The hemispheres were dried for 24 hours at 110uC to
determine the dry weight. Based on gravimetrical differences water
content was obtained by the following calculation: Hemispheric
brain water content (%): (wet weight WW – dry weight DW)/
WW6100.
Tissue preparation for qPCR
For the determination of mRNA regulation, brains were gently
removed and placed in a cooled (6uC) brain matrix. A 2 mm thick
coronal slice was cut and separated in quadrants. The slice was
defined according to the Mouse Brain Library atlas as bregma
21 mm to bregma 23 mm (www.mbl.org). The right-upper
region was collected, frozen in liquid nitrogen and stored at
280uC until further processing. RNA extraction, cDNA synthesis
and real-time PCR was performed with standard protocols as
previously described in detail [15]. RNA concentration was
spectrometrically calculated using NanoVue (GE Healthcare
Europe, Munich, Germany). 0.5 mg extracted RNA was reverse-
transcribed into cDNA by VersoTM cDNA Kit (ABgene,
Hamburg, Germany) according to the manufacturer’s instructions.
cDNA of each sample was amplified by a real-time Lightcycler
480 PCR System (Roche). Equal amounts of cDNA (1 ml) were
used in duplicates and amplified with LightcyclerH 480 Probes
Master or LightcyclerH 480 SYBR Green I Master (Roche). Real-
time cycling parameters were as follows: thermal activation for
10 min at 95uC and 50 cycles of PCR (melting for 10 s at 95uC,
annealing for 10 s at 55uC (for HybProbe assays) or according to
Table 1, extension for 15 s at 72uC). Applied primers and probes
are listed in Table 1. A standard curve for absolute quantification
was generated with PCR DNA for each PCR product (101–107).
The absolute copy numbers of the target genes was normalized
against the absolute copy numbers of Cyclophilin A (PPIA) as
control gene.
Immunohistochemistry
24 hours after CCI or sham surgery the initial anesthetic
regimen was repeated for deep anesthesia and the animals were
transcardially perfused using 4% paraformaldehyd (PFA). The
brains were carefully removed and postfixed in 4% PFA for
24 hours. Subsequently brains were washed in 0.01 mol/l PBS
and incubated in sucrose (30% in 0.01 mol/l PBS) overnight at
RT under stiring. Brains were cut into 100 mm thick slices with a
freezing microtome (Leitz CM 1325, New York, NY, USA). For
co-stainings of ZO-1, cl5 and counterstaining of cell nuclei with
49,6-Diamidino-2-phenylindole dihydrochloride (DAPI from Sig-
ma, 1:2000) mice were transcardially perfused with PBS. Then
brains were removed, embedded in tissue tek and snap frozen.
Frozen brains were cryosectioned (10–20 mm) and fixed in ice-cold
acetone. Slices were blocked and permeabilized with 7% normal
goat serum (Jackson ImmunoResearch via Dianova, Hamburg,
Germany) and 0.3% triton (Sigma-Aldrich Steinheim, Germany)
in PBS 0.01 mol/l for 2 hours at RT. For immunohistochemical
staining slices were incubated with the primary antibodies (1:100
rabbit anti-ZO-1 or 1:50 mouse anti-claudin-5, Invitrogen via
Zymed) in 2% bovine serum albumin (Dianova) with 0.05% azide
and 0.1% Triton in PBS 0.01 mol/l overnight at RT. Then probes
were incubated with secondary antibodies (CyTM2-conjugated
AffiniPure goat anti-rabbit IgG H+L, Dianova; or Alexa Fluor 568
goat anti-mouse, molecular probes) diluted in 2% bovine serum
albumin for 2 hours at RT. Probes were washed in PBS 0.01 mol/
l and embedded in Fluoromount (Southern Biotech, Birmingham,
AL, USA) or Fluorsave (Calbiochem San Diego, CA, USA).
For cl5 staining in PFA fixed probes sections were unmasked
with citric acid monohydrate (Roth, Karlsruhe, Germany)
0.01 mol/l pH 6.0 on superfrost-slides (Menzel, Braunschweig,
Germany) in the microwave (boiling ,2 minutes) ahead of
antibody application.
Immunofluorescence confocal microscopy (ICM)
An upright microscope (BX51WI, Olympus; Hamburg, Ger-
many) with a Nipkow spinning disk confocal system (QLC10
Visitech, Sunderland, United Kingdom) and a Krypton/Argon
laser (Laser Physics, Cheshire, UK) was used for ICM. Fluorescent
probes were excited at 488 nm and 568 nm wavelength. For
three-color analyses of cl5, ZO-1, and DAPI a Leica SP5 confocal
laser-scanning microscope was used. Here excitations were
405 nm, 488 nm, and 561 nm wavelength. Images were analyzed
and processed with Leica Application Suite Advanced Fluores-
cence (Leica Microsystems), Metamorph (Molecular Devices
Corp., Downington, CA, USA) and ImageJ (NIH software).
Quantification of TJ gap formation in CCI
ZO-1 and cl5 gap formation was analyzed as described before
[11] with modifications using ImageJ software. The length of ZO-
1 or cl5 disruptions was related to the total length of cerebral
microvessels and TJ gap formation was calculated as percentage of
the total number of investigated TJs. For statistical analyses 20–26
microvessels from 3 brains were analyzed per group in the
pericontusional area.
Statistical Analysis
Statistical analysis was performed with Sigma Plot 11 statistical
software (SPSS Science, Chicago, USA) and Graph Pad Prism
(Windows version 4.02, GraphPad Software, San Diego, CA,
USA). TEER and microvascular measurements were analyzed by
ANOVA and post hoc Tukey tests (study A and D). Wilcoxon
Mann Whitney Rank Sum Tests were used in study B, C–E and p-
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values were adjusted for multiple comparisons (Bonferroni
adjustment). A value of P,0.05 was considered as significant.
Results are presented as mean 6 standard deviation (SD).
Results
Effect of anesthetics on in-vitro blood brain barrier
integrity
To analyze BBB integrity TEER values at 0 hours before gas
exposure and 24 hours after gas exposure TEER values were
evaluated, and for normalization purposes the values for both time
points were set in relation to average TEER values before gas
exposure, respectively (Figure 1). In a monoculture model both
volatile anesthetics isoflurane (0 h= 160.05 vs. 24 h= 0.8760.13,
P,0.05, n = 8) and sevoflurane (0 h= 160.04 vs.
24 h= 0.8260.14, P,0.001, n= 8) significantly reduced TEER
(Figure 1 A) after 24 hours of gas exposure (airR
24 h=1.0360.04 vs. isoflurane 24 h 0.8760.13, P,0.01; airR
24 h=1.0360.04 vs. sevoflurane 24 h= 0.8260.14, P,0.001,
n = 8). Although the reduction of TEER was higher after sevo
exposure, there were no significant differences between the two
volatile anesthetics. Room air had no significant effect on TEER
values after 24 h (airR 0 h=160.03 vs. airR 24 h= 1.0360.04,
P.0.05, n= 8).
In the co-culture model (Figure 1 B) volatile anesthetics and
room air had no significant impact on TEER (isoflurane
0 h= 160.08 vs 24 h 1.0460.1; sevoflurane 0 h= 160.06 vs.
24 h= 1.0460.07; room air 0 h= 160.03 vs. room air 24 h
1.0260.05, P.0.05 in all groups, n= 8) and ZO-1 or cl5 integrity
(Figure 1 C–K).
Effect of anesthesia on brain water content and TJ
protein expression in native animals
To investigate the impact of anesthesia on brain water content
in healthy animals, hemispherical water content was determined
by measuring the wet/dry ratio (Figure 2). 1.5% isoflurane, 3.5%
sevoflurane or no anesthesia was initiated for 20 minutes. 24 hours
after anesthesia exposure brain water content was not significantly
different between the experimental groups (no anesthesia [40%
O2]= 79.6660.4%, isoflurane = 79.5160.4%, sevoflur-
ane = 79.8660.9%). Expression of the TJ proteins cl5, ZO-1
isoform 1 (ZO-1 V1), and ZO-1 isoform 2 (ZO-1 V2) was not
significantly different in native animals 24 hours after anesthesia
exposure (Figure 3).
Effect of anesthesia on brain water content after CCI
In order to investigate if anesthetics influence brain water
content after an acute cerebral lesion wet/dry ratio was
determined 24 hours after CCI or sham surgery (Figure 4).
The water content of the injured hemisphere increased signifi-
cantly in both groups (sevoflurane+CCI= 79.6260.5%, P,0.05;
isoflurane+CCI= 79.8960.5%, P,0.01) 24 hours after CCI in
comparison to sham-operated animals (sevoflurane+sham sur-
gery = 78.6460.6%; isoflurane+sham surgery = 78.4560.7%).
Compared to sham operated animals, brain water content of
traumatized animals demonstrated a significant higher increase
with isoflurane (+1.7760.5%, P,0.05) compared to sevoflurane
(+0.7760.3%).
Tight junction integrity in the pericontusional region
Tight junction protein integrity is a hallmark for brain edema
progression in pathologic conditions such as stroke [16]. It has
been documented that the TJ proteins ZO-1 and cl5 have a pivotal
role for the integrity of the BBB in this context [17]. To elucidate
whether these proteins also have a major role in CCI, the
pericontusional area of CCI brains (Figure 5 A) was analyzed
quantitatively for ZO-1 and cl5 gap formation in cerebral
microvessels (Figure 5 B). ZO-1 was more affected by CCI than
cl5 in both sevoflurane (ZO-1 sevoflurane CCI 31.6620.1% vs.
cl5 sevoflurane CCI 568.1%, P,0.001, n= 20–26 microvessels, 3
brains per group) and isoflurane (ZO-1 isoflurane CCI
27.5625.5% vs. cl5 isoflurane CCI 8.2612.7%, P,0.001,
n = 22 microvessels, 3 brains per group). The choice of the volatile
anesthetics isoflurane or sevoflurane did not significantly alter cl5
or ZO-1 gap formation after CCI (ZO-1 sevoflurane CCI
31.6620.1% vs. ZO-1 isoflurane CCI 27.5625.5%, P.0.05,
Table 1. Specific primer and probes and optimized temperature conditions for real-time PCR.
PCR assay
(amplicon size, annealing temp) Oligonucleotide Sequence (59-39) GenBank No.
Claudin-5 (cl5) Forw: 59-CGTTGGAAATTCTGGGTCTG-39 NM_013805.4
(194 bp, 58uC, A:10s, E:15s) Rev: 59-AGATTCATACACCTTGCACTG-39
ZO-1 isoform 1 (ZO-1 V1) Forw: 59-TgTCCCTgTgAgTCCTTCAg-39 NM_009386.2
(331 bp, 55uC, A:10s, E:15s) Rev: 59-CCAggTTTTAgggTCACAgT-39
Red: R610-ATgCCACgAgCTgTAgCCACTAC-Phos
FL: 59-CTCAACACACCACCATTgCTgTT-FL
ZO-1 isoform 2 (ZO-1 V2) Forw: 59-TgTCCCTgTgAgTCCTTCAg-39 NM_001163574.1
(330 bp, 55uC, A:10s, E:15s) Rev: 59-ggAgTCATggACgCACAgT-39
Red: R610-ATgCCACgAgCTgTAgCCACTAC-Phos
FL: 59-CTCAACACACCACCATTgCTgTT-FL
Cyclophilin A (PPIA) Forw: 59-gCgTCTSCTTCgAgCTgTT-39 NM_008907
(146 bp, 55uC, A:10s, E:15s) Rev: 59-RAAgTCACCACCCTggCA-39 [15]
Red: R610-TTggCTATAAgggTTCCTCCTTTCACAg-Phos
FL: 59-gCTCTgAgCACTggRgAgAAAggA-FL
Forw= sense primer; Rev = anti-sense primer, R610 = LightcyclerH Red610, Phos = phosphate, FL = fluorescein.
doi:10.1371/journal.pone.0050752.t001
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n=20–22 microvessels, 3 brains per group; cl5 sevoflurane CCI
568.1% vs. cl5 isoflurane CCI 8.2612.7%, P.0.05, n = 22–26
microvessels, 3 brains per group). Further, we compared ZO-1
and cl5 TJ impairment in sham animals with the CCI groups.
Here it became apparent that ZO-1 is significantly disrupted in the
pericontusional area whilst cl5 is not significantly altered in the
pericontusional zone compared with sham animals in isoflurane as
well as in sevoflurane groups (ZO-1 sevoflurane CCI 31.6620.1%
vs. ZO-1 sevoflurane sham 2.964.2%, P,0.001, n= 20 micro-
vessels, 3 brains per group; ZO-1 isoflurane CCI 27.5625.5% vs.
ZO-1 isoflurane sham 5.5613.3%, P,0.001, n = 22 microvessels,
3 brains per group; cl5 sevoflurane CCI 568.1% vs. cl5
sevoflurane sham 2.163.5%, P.0.05, n= 21–26 microvessels, 3
brains per group; cl5 isoflurane CCI 8.2612.7% vs. cl5 isoflurane
sham 2.963.9%, P.0.05, n = 21–22 microvessels, 3 brains per
group). No significant differences in TJ damage were observed in
sham groups treated with sevoflurane or isoflurane. The
pericontusional area of CCI and sham brains (Figure 5) was
analyzed with ICM. Prominent ZO-1 disruptions were detected in
the pericontusional area in animals that were treated with
sevoflurane (Figure 5 C and F) or isoflurane (Figure 5 D and
G) during CCI induction. In sham isoflurane or sevoflurane
animals only slight ZO-1 discontinuities were found (Figure 5 E
and H). Fewer cl5 disruptions were present in CCI brains that
were exposed to sevoflurane (Figure 5 I and L) or isoflurane
(Figure 5 J and M). Only sparse cl5 dislocation was present in
sham animals (Figure 5 K and N). Apparently, ZO-1 was more
affected by CCI in the pericontusional zone than cl5. To better
evaluate the discrepancy observed in cl5 and ZO-1 impairment we
performed triple labeling of cl5, ZO-1 and cell nuclei with DAPI.
Representative co-stainings of 3 animals per group are shown. In
sham groups treated with sevoflurane (Figure 6 A–C) or
Figure 1. Effect of isoflurane and sevoflurane on TEER in vitro. (A) In a monoculture model bEnd.3 cells were exposed for 20 minutes to
room air only (airR), airR containing 1.5% of either isoflurane or 3.5% of sevoflurane. After 24 hours TEER values were evaluated. airR had no effect on
TEER whilst iso and sevo significantly reduced TEER values. (B) In an in vitro co-culture model of the BBB that includes most cell types of the NVU
isoflurane or sevoflurane had no significant impact on TEER. Immunohistochemical analyses confirmed that BBB integrity within the BBB co-culture
model was not affected by volatile anesthetics. (C–E) Probes exposed to air only demonstrated a continuous alignment and co-localization of cl5 and
ZO-1 in the BBB co-culture model. No differences in cellular integrity of cl5 and ZO-1 were found in probes treated with (F–H) sevoflurane or (I–K)
isoflurane. (E, H, K) Note the physiological co-localization of cl5 and ZO-1.
doi:10.1371/journal.pone.0050752.g001
Figure 2. Brain edema formation in native animals. 24 hours
after 20 minutes exposure with 1.5% isoflurane, 3.5% sevoflurane or
pure O2/N2 mixture (no anesth.) exposure brain water content was
determined in native animals. The anesthesia exposure did not
influence brain water content.
doi:10.1371/journal.pone.0050752.g002
Figure 3. Influence of isoflurane and sevoflurane on TJ protein
expression in native animals. Expression of the TJ proteins cl5 (A),
ZO-1 isoform 1 (ZO-1 V1, B), and ZO-1 isoform 2 (ZO-1 V2, C) was
determined 24 hours after exposure to isoflurane and sevoflurane and
compared to no anesthesia (same O2/N2 mixture). The expression of the
TJ proteins was not significantly different between groups (n = 8/group;
p-values are adjusted for multiple comparison by Bonferroni).
doi:10.1371/journal.pone.0050752.g003
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isoflurane (Figure 6 D–F) a continuous TJ expression in cortical
microvessels with only sparse TJ disruptions (arrowheads in A–E)
were present. In both sham groups cl5 and ZO-1 co-localized in a
physiological manner (C and F). In CCI groups treated with
sevoflurane cl5 (G, arrowheads) was less disrupted than ZO-1 (H,
arrowheads) as demonstrated in the merged image in I. A similar
result was obtained in CCI animals treated with isoflurane. Here,
cl5 integrity (J, arrowheads) was also much less affected than ZO-1
(K, arrowheads) as shown in the overlay in L. However, both
junctional proteins cl5 and ZO-1 displayed disruptions within the
CCI core region (data not shown).
Tight junction mRNA expression in the pericontusional
region
In contused brain tissue mRNA content of cl5 was not
significantly altered 15 minutes and 24 hours after trauma both
for the sevoflurane as well as for the isoflurane group (Figure 7 A).
The amount of ZO-1 isoform 1 (ZO-1 V1: 15 min sevoflur-
ane = 131615% native vs. isoflurane = 10867% native; 24 h
sevoflurane = 154618% native vs. isoflurane = 128616% native,
Figure 7 B) and ZO-1 isoform 2 (ZO-1 V2: 15 min sevoflur-
ane = 122610% native vs. isoflurane = 10469% native; 24 h
sevoflurane = 123618% native vs. isoflurane = 112610% native,
Figure 7 C) copies was significantly higher in the sevoflurane
group compared to the isoflurane group at all time points.
Discussion
Blood-brain barrier breakdown results in brain edema forma-
tion, which is one major cause for the high mortality rate after
severe brain injury. Tight junction proteins such as ZO-1 and cl5
play a critical role to maintain BBB function by improving the
barrier function at the endothelial level [10,11,18]. Our data
suggest that anesthetics differentially influence BBB permeability.
The key findings of this study are: 1.) Sevoflurane and isoflurane
reduce transendothelial electrical resistance of in-vitro BEC but
not in a more complex co-culture model of the BBB; 2.) Following
TBI brain water content in isoflurane-anesthetized animals was
higher than in brains of sevoflurane-treated animals; 3.) ZO-1
integrity on the cellular level is more affected by TBI than cl5
whilst isoflurane or sevoflurane had no impact on microvascular
TJ integrity; 4.) Sevoflurane application is associated with a
stronger ZO-1 expression after TBI compared to isoflurane. The
data therefore indicate that volatile anesthetics differentially
influence the integrity of BBB for a prolonged phase after
exposure.
An intact BBB is essential for the fluid and substrate homeostasis
of the brain and disruption results in disturbance in regulation of
brain water balance and consecutive brain edema formation.
Brain edema is considered to be one of the central pathophysi-
ological events worsening outcome by raising intracranial pressure
and impairing cerebral perfusion [2].
Following TBI anesthetics are routinely applied during intensive
care or surgical procedures; and they are even utilized to reduce
cerebral metabolisms and blood volume during phases of elevated
ICP. So far, it is unclear if volatile anesthetics are capable of
inducing BBB impairment at the endothelial level. However it has
been recently demonstrated that in an in vitro model of astrocyte-
conditioned human umbilical vein endothelial cells isoflurane is
capable of inducing apoptosis [19]. The bEnd.3 cell line is a model
of murine cerebrovascular endothelium maintaining several in-
vivo properties of the BBB like expression of tight junction proteins
[10,20], permeability to sucrose, high trans endothelial electrical
resistance as well as transport of glucose [20]. The neurovascular
in vitro co-culture consists of most cell types of the neurovascular
unit (NVU) including neurons and astrocytes. In the bEnd.3
monoculture model, exposure towards the volatile anesthetics
isoflurane and sevoflurane induced a decrease of TEER. TEER
correlates with BBB integrity in vitro [19]. At this point we would
like to stress the fact that absolute TEER values evaluated in ECIS
are not comparable to TEER values evaluated in cell culture
inserts that include porous membranes. A detailed description of
the method itself can be found in the work by Tirppathi et al. [21].
However, we have previously demonstrated that impaired TEER
values in ECIS within bEnd.3 monolayers as well as the
neurovascular BBB model go along with disruptions in cl5 and
ZO-1 [10,11].
Volatile anesthetics like isoflurane and sevoflurane are potent
direct vasodilators [22] – vasodilatation of the vessels, induced by
isoflurane has been reported to initiate BBB disruption [7]. In
Figure 4. Brain edema formation in traumatized mice. (A) Brain water content was determined 24 hours after CCI or sham operation. The
water content of the right hemisphere in the sevoflurane and isoflurane group increased significantly in comparison to sham operated animals.
Increase of brain water content differed depending on anesthetics. (B) For the absolute increase of brain water content, the difference of brain water
content of sham operated and traumatized animals exposed to the same anesthetics was calculated. Compared to sham values, increase in brain
water content was significantly higher with isoflurane compared to sevoflurane.
doi:10.1371/journal.pone.0050752.g004
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Figure 5. Immunohistochemical analysis of ZO-1 and cl5 gap formation in the pericontusional brain area. (A) Immunohistochemical
analyses were performed in the pericontusional cortical area (marked by the grey box) of CCI and (B) sham brains. (B) CCI resulted in heavy ZO-1
impairment in cerebral microvessels while cl5 was not significantly impaired (ZO-1 sevoflurane CCI 31.6620.1% vs. ZO-1 sevoflurane sham 2.964.2%,
Blood Brain Barrier Integrity and Anesthetics
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contrast to the in-vitro monoculture results, the brain water
content in sham operated and in native animals did not differ
significantly independent of exposure to volatile anesthetics.
Further we did not observe a significant impact of sevoflurane
or isoflurane on TEER and TJ integrity within an in-vitro model
that consists of most cell types of the neurovascular unit [10]. This
is in agreement with our observation that BBB function does not
seem to be affected in native animals exposed to sevoflurane or
isoflurane. Healthy brain tissue and a complex model of the BBB
therefore seem to compensate changes introduced by the
application of both volatile anesthetics, while in-vitro brain
endothelial cells are not able to solely maintain barrier function
P,0.001, n = 20 microvessels, 3 brains per group; ZO-1 isoflurane CCI 27.5625.5% vs. ZO-1 isoflurane sham 5.5613.3%, P,0.001, n = 22 microvessels,
3 brains per group; cl5 sevoflurane CCI 568.1% vs. cl5 sevoflurane sham 2.163.5%, P.0.05, n = 21–26 microvessels, 3 brains per group; cl5 isoflurane
CCI 8.2612.7% vs. cl5 isoflurane sham 2.963.9%, P.0.05, n = 21–22 microvessels, 3 brains per group). Impairment of ZO-1 in CCI was significantly
higher than cl5 damage in sevoflurane (ZO-1 sevoflurane CCI 31.6620.1% vs. cl5 sevoflurane CCI 568.1%, P,0.001, n = 20–26 microvessels, 3 brains
per group) and isoflurane (ZO-1 isoflurane CCI 27.5625.5% vs. cl5 isoflurane CCI 8.2612.7%, P,0.001, n = 22 microvessels, 3 brains per group)
groups. ZO-1 and cl5 gap formation was not significantly affected during CCI by the choice of the volatile anesthetic (ZO-1 sevoflurane CCI
31.6620.1% vs. ZO-1 isoflurane CCI 27.5625.5%, P.0.05, n = 20–22 microvessels, 3 brains per group) or iso (cl5 sevoflurane CCI 568.1% vs. cl5
isoflurane CCI 8.2612.7%, P.0.05, n = 22–26 microvessels, 3 brains per group). (C–N) Representative confocal images of TJ damage. Numerous ZO-1
disruptions were found in CCI animals treated with sevoflurane (panels C and F) or isoflurane (D and G). ZO-1 discontinuities in sham animals were
sparse (representative images of ZO-1 in sham animals in E and H). Only few cl5 disruptions were present in CCI in both sevoflurane (I and L) and
isoflurane (J, M) in comparison to sham brains (representative images of cl5 in sham animals in K, N).
doi:10.1371/journal.pone.0050752.g005
Figure 6. Triple-staining of DAPI, ZO-1 and cl5 in the pericontusional brain area of CCI and sham animals. (A) cl5 and (B) ZO-1
immunoreactivity in sham sevoflurane treated animals demonstrate a physiological co-localization as shown in (C). In sham animals exposed towards
isoflurane (D) cl5 and (E) ZO-1 displayed a similar physiological (F) co-localization of the junctional proteins. TJ disruptions in sham animals were
sparse as indicated by the white arrows in A–F. In CCI brains of the sevoflurane group a significant discrepancy of (G) cl5 and (H) ZO-1 became
apparent as shown in (I). In the isoflurane CCI group (J) cl5 was also less affected by CCI than (K) ZO-1. Here a similar discrepancy as in CCI
sevoflurane treated animals was found (L). TJ disruptions in ZO-1 were significantly increased compared with ZO-1 sham animals. No difference in cl5
disruptions was observed (G–L, see also quantification of TJ disruptions in Figure 5). Note the microvascular brain endothelial nuclei marked with
asterisks (insets in C, F, I, L).
doi:10.1371/journal.pone.0050752.g006
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upon volatile anesthetic stimulation. The in-vitro model of a
monoculture of bEnd.3 is therefore a very sensitive tool to detect
BBB dysfunction, but in the experimental setting of the present
study it overestimates the potential effect in healthy brain tissue.
Most likely the reason is that it does not represent a functional
neurovascular unit as it is found in vivo [10]. However, TBI results
in spreading depolarization that significantly perturb the physio-
logic interplay of the NVU [20], which may also make the brain
endothelium more vulnerable towards injury. Our data suggest
that in conditions where some cell types of the NVU are lacking or
are not physiologically regulated, an enhanced level of vulnera-
bility towards the brain endothelium is present.
Volatile anesthetics have been shown to influence edema
formation in injury models in other organ systems, e.g. a recent
study demonstrated that the development of lung edema was
enhanced by isoflurane and not by sevoflurane in an animal model
of pulmonary injury [23]. Isoflurane in conjunction with
mechanical ventilation blunted cardiovascular compensatory
mechanisms in sepsis and enhanced leukocyte activation, which
may also contribute to lung edema formation [24]. Possibly, in the
context of TBI anesthesia may also have an impact on brain water
content following experimental head injury. The time-course
experiments of brain edema formation following brain trauma
demonstrate an increase of brain water content already 2 hours
after insult with a maximum after 24 hours [25,26]. The
disruption of the BBB integrity occurs immediately after insult
and reaches a maximum after 4–6 hours and a second peak 3 days
after brain injury [25]. In the present study brain water content
increased significantly after trauma in all groups compared to
sham operated animals 24 hours after brain trauma. The extent of
increase differed depending on the anesthetics - being highest with
isoflurane and lowest with sevoflurane. Apart from neuroprotec-
tive effects of volatile anesthetics [27,28], different anesthetics also
increase cerebral water content in animals with or without brain
injury [7]. Currently no data is available on the effect of
sevoflurane on BBB integrity and brain edema formation during
TBI. Animal studies indicate that isoflurane anesthesia impairs
BBB [7], increases plasma glutamate levels and brain water
content in brain-injured rats [29] and raises plasma glutamate
levels in neurosurgical patients [30]. Isoflurane induces a larger
brain edema formation in comparison to pentobarbital in
experimental cerebral ischemia [31]. The potential edema
enhancing effect of isoflurane is dependent upon concentration,
time point, and duration of exposure [7]. An increase in bi-
hemispherical water content was observed in traumatized rats
subjected to 4 hours of isoflurane anesthesia [29]. Contrary to this
finding a low concentration of isoflurane did not result in an
increase in posttraumatic brain edema in rats [32]. In non-
traumatized dogs anesthetics also have been shown to increase
cerebral water content [33]. Already a short duration of isoflurane
increased water content in the pyriform cortex in uninjured rat
brains [34]. Multiple data therefore demonstrate a modulatory
effect of anesthetics on BBB function – which may be caused by
their direct action on cerebral vessels. An increase of cerebral
blood flow (CBF) and vasodilation is associated with an increase of
brain water content [35]. Volatile anesthetics have effects on
cerebral vasodilation, cerebral blood volume, CBF, and ICP in a
dose dependent manner [36,37]. During propofol-induced
isoelectric electroencephalography isoflurane treatment in patients
resulted in a higher CBF in the middle cerebral artery than under
sevoflurane anesthesia [36]. Sevoflurane has been reported to
decrease CBF in a dose dependent manner in pigs [38] in contrast
to data on isoflurane reported by the same group [39]. On the
contrary sevoflurane and isoflurane have been shown to have
similar effects on CBF in animals and humans [22,40,41].
Therefore, the vasodilatory effects of these anesthetics cannot
explain the observed differences in this study.
Figure 7. Influence of isoflurane and sevoflurane on TJ protein
expression after CCI. Expression of the TJ proteins cl5 (A), ZO-1
isoform 1 (ZO-1 V1, B), and ZO-1 isoform 2 (ZO-1 V2, C) was determined
at 15 minutes and 24 hours after CCI injury and exposure to isoflurane
(iso)/sevoflurane (sevo) and is expressed as % of native animals (n = 6/
15 min groups; n = 8/24 h groups; p-values are adjusted for multiple
comparison by Bonferroni).
doi:10.1371/journal.pone.0050752.g007
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The permeability of the BBB is modulated by the cellular
localization, expression and by protein-protein interaction of the
TJ proteins. A wide array of growth factors, cytokines, drugs,
caspase-3 [11], matrix metalloproteinases [42], and hormones
influence tight junctions and barrier function. For example,
steroids [43] or unsaturated fatty acids [44] enhance the tight
junction tightness by increasing the expression of occludin.
Histamin, caspase-3 [11], cytokines, VEGF (review: [45]), and
tumor necrosis factor-a [46] perturb TJ integrity by decreasing
occludin and ZO-1 expression and causing cl5 and ZO-1 protein
disruption. TJs are regulated by a diverse group of extracellular
stimuli that initiate various intracellular signaling cascades.
Further, ischemic [47] or traumatic [48] insults reduced both
ZO-1 and occludin levels or resulted in impaired TJ alignment
[11]. In the present study TJ proteins critical to maintain BBB
function (cl5 and ZO-1) were investigated. TBI resulted in a
disruption of ZO-1 and cl5 protein interaction 24 hours following
CCI. ZO-1 was more susceptible towards cellular disturbances
after TBI than cl5. The discrepancy between ZO-1 and cl5
impairment is an important finding: recently it has been
documented that a targeted suppression of cl5 is beneficial for
outcome and reduces brain edema evolution in vivo [18]. These
results suggest that the persistence of cl5 in the pericontusional
zone may be of pivotal importance for outcome in TBI. Isoflurane
and sevoflurane did not have an effect on these changes. However,
the mRNA expression of ZO-1 was higher in the sevoflurane
group compared to native and isoflurane treated animals.
Isoflurane did not significantly alter TJ protein cl5 and ZO-1
expression on the mRNA level.
The present data demonstrate that isoflurane treatment resulted
in a significant elevation in brain water content in a model of TBI.
In contrast lower brain water levels were found after treatment
with sevoflurane. Sevoflurane increased ZO-1 mRNA expression
which was beneficial for BBB integrity as reflected by a reduced
brain edema in sevoflurane treated animals after TBI. The present
data suggest that the difference in extent of brain edema formation
after brain trauma by use of sevoflurane for anesthesia may be
dependent upon ZO-1 impairment on the cellular and mRNA
level. Although TJ proteins, especially ZO-1, are disrupted after
TBI, a higher mRNA expression of ZO-1 correlated with less
increase in brain water content.
Conclusion
The study demonstrates that isoflurane and sevoflurane
influence brain edema formation after experimental brain injury
and the expression of ZO-1 on mRNA level. Therefore, the
selection of anesthetics may influence the barrier function. The
observed effect indicate 1.) a strong bias introduced by the
selection of the anesthesia to experimental research on patho-
physiological mechanisms of BBB dysfunction and 2.) a possible
clinical implication to modulate the BBB function by selection of
sevoflurane as anesthetic agent during posttraumatic surgical
procedures.
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